Literature DB >> 11035432

Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease.

J Seguí1, M Ramos-Casals, M García-Carrasco, T de Flores, R Cervera, M Valdés, J Font, M Ingelmo.   

Abstract

The objective was to analyze psychiatric disorders and psychosocial dysfunction in patients with systemic lupus erythematosus (SLE), studied longitudinally during active and subsequent inactive stage of their disease. During a 6 month period of study, we selected 20 consecutive patients with SLE who presented with a SLE flare. All patients fulfilled the 1982 revised criteria of the American College of Rheumatology for the classification of SLE. When patients entered the study, we performed psychiatric (CIS, RDC, STAI, HD, BDI, GHQ and MMS) psychosocial (GAS and VAS-P) scores assessment. One year later, we repeated the psychiatric and psychosocial assessment when patients showed inactive disease. The 20 patients evaluated were women, with a mean age of 34 y (SE 14.4, range 20-57). According to CIS evaluation, we diagnosed 8 (40%) psychiatric cases in the acute episode of SLE. The RDC diagnosis showed generalized anxiety in 5 patients, panic disorders in 2 patients and generalized anxiety plus depressive symptoms in one patient. One year later, when patients did not show disease activity, we diagnosed 2 (10%) psychiatric cases (P<0.05). When SLE patients were clinically inactive, they showed lower levels of psychological distress (GHQ scale, 1.8 vs 5.6, P<0.001), with a lower grade of anxiety measured by both HA (3.2 vs 8.2, P<0.01) and STAI-S (7.95 vs 20.90, P<0.001) scales. We also found a lower score in pain perception (VAS-P) (2.80 vs 4.25, P<0. 01) and higher occupational activity (VAS-P) (83.9 vs 66.2, P<0.01) and general functioning (GAS) (93.75 vs 83.50, P<0.05) during the inactive stage. No significant differences were found when we compared cognitive impairment, grade of depression and physical disability between inactive and active stages. We conclude that in SLE patients, psychiatric and psychosocial disorders during acute episodes are usually mild and seem to be related to the psychological impact of disease activity on patients. This type of psychiatric pathology is similar to that which would be expected in other groups coping with a stressful event, indicating that our patients did not react in a way specifically determined by their systemic disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035432     DOI: 10.1191/096120300678828730

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  11 in total

1.  Damage accrual, cumulative glucocorticoid dose and depression predict anxiety in patients with systemic lupus erythematosus.

Authors:  Anselm Mak; Catherine So-Kum Tang; Moon-Fai Chan; Alicia Ai-Cia Cheak; Roger Chun-Man Ho
Journal:  Clin Rheumatol       Date:  2011-01-11       Impact factor: 2.980

Review 2.  Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction.

Authors:  Philip Watson; Justin Storbeck; Paul Mattis; Meggan Mackay
Journal:  Neuropsychol Rev       Date:  2012-08-11       Impact factor: 7.444

3.  Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.

Authors:  Elizabeth A Bachen; Margaret A Chesney; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2009-06-15

4.  Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration.

Authors:  Tomasz Hawro; Maria Krupińska-Kun; Jolanta Rabe-Jabłońska; Anna Sysa-Jędrzejowska; Ewa Robak; Jarosław Bogaczewicz; Anna Woźniacka
Journal:  Rheumatol Int       Date:  2010-12-07       Impact factor: 2.631

5.  Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies.

Authors:  Fabrizio Conti; Cristiano Alessandri; Daniela Bompane; Michele Bombardieri; Francesca Romana Spinelli; Anna Carlotta Rusconi; Guido Valesini
Journal:  Arthritis Res Ther       Date:  2004-06-17       Impact factor: 5.156

6.  Correlation between physical markers and psychiatric health in a Portuguese systemic lupus erythematosus cohort: The role of suffering in chronic autoimmune disease.

Authors:  Margarida Figueiredo-Braga; Caleb Cornaby; Miguel Bernardes; Marta Figueiredo; Cristina Dos Santos Mesquita; Lúcia Costa; Brian D Poole
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

7.  Anxiety Symptoms Among Patients With Systemic Lupus Erythematosus Persist Over Time and Are Independent of SLE Disease Activity.

Authors:  Daphne Lew; Xinliang Huang; Sara R Kellahan; Hong Xian; Seth Eisen; Alfred H J Kim
Journal:  ACR Open Rheumatol       Date:  2022-02-22

8.  Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study.

Authors:  Andrea Knight; Pamela Weiss; Knashawn Morales; Marsha Gerdes; Allyson Gutstein; Michelle Vickery; Ron Keren
Journal:  Pediatr Rheumatol Online J       Date:  2014-09-10       Impact factor: 3.054

9.  Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus.

Authors:  Mariana Postal; Aline Tamires Lapa; Nailú Angélica Sinicato; Karina de Oliveira Peliçari; Fernando Augusto Peres; Lilian Tereza Lavras Costallat; Paula Teixeira Fernandes; Roberto Marini; Simone Appenzeller
Journal:  J Neuroinflammation       Date:  2016-01-06       Impact factor: 8.322

10.  Measurement properties of the brief resilient coping scale in patients with systemic lupus erythematosus using rasch analysis.

Authors:  José-Antonio López-Pina; Ana-Belén Meseguer-Henarejos; Juan-José Gascón-Cánovas; Dérlis-Julián Navarro-Villalba; Vaughn G Sinclair; Kenneth A Wallston
Journal:  Health Qual Life Outcomes       Date:  2016-09-13       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.